Bilcare Quarterly Results for Trading Insights

BI • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-23 Cr
QSept 2025
Quarterly Results

Bilcare Quarterly Results Key Highlights

  • Revenue of ₹183 Cr in Sept 2025 (-14.9% vs Mar 2025, -11.2% vs Sept 2024)
  • Net Profit of ₹-23 Cr in Sept 2025 (-560.0% vs Mar 2025, +23.3% vs Sept 2024)
  • EBITDA of ₹8 Cr in Sept 2025 (-72.4% vs Mar 2025)
  • Operating Margin of 2.0% in Sept 2025 (-2.0pp vs Mar 2025)
  • Earnings Per Share of ₹-5.25 in Sept 2025 (-217.2% vs Mar 2025)

Bilcare Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 QoQ YoY
Revenue (₹ Cr) 183 215 192 206 209 -14.9% -11.2%
Net Profit (₹ Cr) -23 5 -10 -30 -20 - -
EBITDA (₹ Cr) 8 29 17 2 1 - -
EPS (₹) -5.25 4.48 -1.61 -6.81 -4.63 - -
Operating Margin (%) 2.0% 4.0% 6.0% -1.0% -4.0% - -

Bilcare Share Price Trend Around Quarterly Results

Visualize Bilcare's 1-year price movement across quarterly results — ideal for logging trades in Bilcare share price chart using Tickjournal. All values in ₹.

Related Pages for Bilcare

Additional stock information and data for BI

BI institutional holdings
BI book value
BI market cap trends
BI quarterly financials
Bilcare share price today live chart
BI fair value
BI price earnings ratio

Profitability Ratios

Profit Margin -12.6%
EBITDA Margin 4.4%
Operating Margin 2.0%
ROE (Annual) -15.6%

Balance Sheet Highlights

Total Assets ₹1,417 Cr
Total Equity ₹590 Cr
Current Assets ₹343 Cr
Current Liabilities ₹488 Cr

Cash Flow Analysis

Operating Cash Flow ₹63 Cr
Investing Cash Flow ₹-106 Cr
Financing Cash Flow ₹36 Cr
Net Cash Flow ₹-8 Cr

Current Market Data

Current Price ₹77.24
Exchange BSE
Last Updated Jan 06, 2026

Revenue Trend (₹ Cr)

Sept 2024 206
Jun 2025 192
Mar 2025 215
Sept 2025 183

Net Profit Trend (₹ Cr)

Sept 2024 -30
Jun 2025 -10
Mar 2025 5
Sept 2025 -23

Operating Margin Trend (%)

Sept 2024 -1.0%
Jun 2025 6.0%
Mar 2025 4.0%
Sept 2025 2.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Bilcare quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹412,613.60 Cr 1760.2 14,875 3,125 +10.8% - 21.0% 135.4
Divis Laboratories
Sept 2025 		₹169,700.80 Cr 6642.5 2,860 689 +7.1% - 24.1% 255.8
Torrent Pharmaceuti…
Sept 2025 		₹129,171.09 Cr 3936.8 3,219 591 +11.3% - 18.4% 224.4
Cipla
Sept 2025 		₹121,238.47 Cr 1530.8 7,716 1,353 +12.0% - 17.5% 91.5
Dr Reddys Laborator…
Sept 2025 		₹104,570.84 Cr 1256.2 9,135 1,337 +1.1% - 14.6% 77.6
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores